LeaderPortfolio
Piaoyang
Sun Piaoyang
Rank #312
CHINAHealthcarePharmaceuticals

Sun Piaoyang

Net Worth
$10.524B
+1.22% (24h)
Sun Piaoyang, a prominent figure in the Chinese pharmaceutical industry, is the chairman of Jiangsu Hengrui Medicine, a leading producer of anti-infection and cancer medications. Born in 1958, he holds degrees from China Pharmaceutical University and Nanjing University. Under his leadership, Hengrui has transformed into a global pharmaceutical powerhouse, driving significant investments in research and development and achieving numerous breakthroughs in cancer treatment and other critical areas. With an estimated net worth of $12.0 billion, Sun has solidified his position as a key player in the healthcare sector, known for his commitment to innovation, patient-centered care, and sustainable growth.

How to read Sun Piaoyang's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Sun Piaoyang, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $10.524B alongside global rank #312, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (CHINA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life and Education

Sun Piaoyang was born in 1958 in Lianyungang, China. He demonstrated exceptional academic abilities early on. He earned a bachelor's degree from China Pharmaceutical University and a doctoral degree from Nanjing University. His education laid the foundation for his successful career in the pharmaceutical industry.

Rise to Success

Sun Piaoyang began his career at the state-run Lianyungang Pharmaceutical Factory. In 1990, at the age of 32, he took over the company, which later became Jiangsu Hengrui Medicine. Under his leadership, Hengrui transformed from a small, state-owned factory into one of China's largest pharmaceutical companies. He spearheaded a shift towards innovation and research, particularly in oncology and cardiovascular treatments. The company's focus on research and development significantly boosted its market value.

Key Business Strategies

Sun Piaoyang's strategy focused on innovation and expanding into high-demand areas. He increased investments in research and development, setting Hengrui apart from other pharmaceutical companies in China. He led Hengrui to focus not only on manufacturing generic drugs but also on developing innovative treatments, particularly in oncology and cancer therapies. Sun also emphasized patient-centered innovation, aiming to address critical medical needs, especially for diseases like cancer. He also promoted global expansion and strategic partnerships, including securing international approvals for key medicines.

Philanthropy

Sun Piaoyang and his wife, Zhong Huijuan, were featured on the Hurun Philanthropy List in 2019 for their contributions to medical aid.

Career Timeline

2025

Led the firm to complete a Hong Kong listing

The listing raised $1.3 billion.

2000

Jiangsu Hengrui Medicine went public

Led the firm to go public in Shanghai, boosting the company's financial standing and positioning it as a leading player.

1990

Took over Jiangsu Hengrui Medicine

Became the head of the formerly state-led Jiangsu Hengrui Medicine, transforming it into a leading pharmaceutical company.

Philanthropic Impact

Medical AidUnknown

Medical Aid

Sun Piaoyang and his wife Zhong Huijuan were featured on the Hurun Philanthropy List in 2019 for their contributions to medical aid.

Key Business Ventures & Holdings

CompanyStakeValue
Jiangsu Hengrui Medicine90.00%

Net Worth History

In-Depth Analysis

Early Life and Education

Sun Piaoyang was born in 1958 in Lianyungang, China. He demonstrated exceptional academic abilities early on. He earned a bachelor's degree from China Pharmaceutical University and a doctoral degree from Nanjing University. His education laid the foundation for his successful career in the pharmaceutical industry.

Rise to Success

Sun Piaoyang began his career at the state-run Lianyungang Pharmaceutical Factory. In 1990, at the age of 32, he took over the company, which later became Jiangsu Hengrui Medicine. Under his leadership, Hengrui transformed from a small, state-owned factory into one of China's largest pharmaceutical companies. He spearheaded a shift towards innovation and research, particularly in oncology and cardiovascular treatments. The company's focus on research and development significantly boosted its market value.

Key Business Strategies

Sun Piaoyang's strategy focused on innovation and expanding into high-demand areas. He increased investments in research and development, setting Hengrui apart from other pharmaceutical companies in China. He led Hengrui to focus not only on manufacturing generic drugs but also on developing innovative treatments, particularly in oncology and cancer therapies. Sun also emphasized patient-centered innovation, aiming to address critical medical needs, especially for diseases like cancer. He also promoted global expansion and strategic partnerships, including securing international approvals for key medicines.

Philanthropy

Sun Piaoyang and his wife, Zhong Huijuan, were featured on the Hurun Philanthropy List in 2019 for their contributions to medical aid.

Data Sources & Methodology

Figures for Sun Piaoyang are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.